Calidi Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $10.0M
Liabilities Breakdown FY2023
Total Liabilities: $18.3M
Asset Breakdown
Total Assets: $10.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.2M | 21.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.3M | 12.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.6M | 65.7% |
Liabilities Breakdown
Total Liabilities: $18.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $2.1M | 11.3% |
| Other Liabilities | $16.2M | 88.7% |